Promega and Aobious Reach Comprehensive Settlement in Patent Infringement Lawsuit Over Bioluminescent Technology Promega Corporation and Aobious Inc. have officially concluded a contentious legal battle over bioluminescent reagent patents, reaching a settlement agreement that addresses a lawsuit involving proprietary furimazine…
Kashiv BioSciences and MS Pharma Forge Strategic Alliance to Bring XOLAIR® Biosimilar ADL-018 to MENA Region Kashiv BioSciences, LLC, a U.S.-based biopharmaceutical company specializing in complex generics and biosimilars, and MS Pharma, a leading pharmaceutical company in the Middle East…
Genmab Appoints Dr. Katja Nielsen as General Manager for Germany, Strengthening European Commercial Expansion Genmab A/S (Nasdaq Copenhagen: GMAB), a global biotechnology leader in antibody-based medicines for cancer and other serious diseases, today announced the appointment of Dr. Katja Nielsen…
European Commission Greenlights AUCATZYL®: AGC Biologics Marks 10th Regulatory Approval with Autolus’ CAR-T Therapy AGC Biologics, a global contract development and manufacturing organization (CDMO) specializing in biologics and advanced therapies, has reached another significant milestone. On July 21, the European…
Altasciences and VoxCell BioInnovation Forge Strategic Partnership to Revolutionize Preclinical Drug Development with 3D Bioprinted Human Tissue Models In a move poised to reshape the landscape of early-stage drug development, Altasciences, a fully integrated drug development solution provider, and VoxCell…
Merz Aesthetics Expands U.S. Leadership Team With Appointment of Sales and Marketing Veterans to Drive National Growth Strategy Merz Aesthetics, the world’s largest company solely dedicated to the field of medical aesthetics, has announced the appointment of two highly experienced…
IntraBio’s AQNEURSA® Gains CHMP Recommendation for Niemann-Pick Disease Type C, Signaling Major Breakthrough in Rare Neurological Disorder Treatment In a landmark development for the rare disease community, IntraBio Inc., a pioneering biopharmaceutical company specializing in therapies for rare and debilitating…
Compass Pathways Appoints Biopharmaceutical Veteran Justin Gover to Board of Directors as Company Advances Toward Potential Regulatory Milestone Compass Pathways plc (Nasdaq: CMPS), a biotechnology company at the forefront of developing innovative mental health treatments, announced today the appointment of…
LEO Pharma Achieves Landmark FDA Approval for ANZUPGO® (Delgocitinib) Cream to Treat Chronic Hand Eczema in U.S. Adults LEO Pharma, a global leader in medical dermatology with a deep-rooted focus on treating serious skin diseases, has announced that the U.S.…
Huonslab Strengthens HYDIZYME™ Pipeline with Formulation Patent, Targeting 2026 Market Launch Huonslab Co., Ltd., a subsidiary of Huons Global (KOSDAQ:084110), has taken a major step forward in its mission to bring innovative biologic formulations to market with the announcement that…
Charles River Teams Up with Elly’s Team to Accelerate Gene Therapy for Ultra-Rare NEDAMSS Disorder Charles River Laboratories International, Inc. (NYSE: CRL), a global leader in early-stage drug development and manufacturing services, has announced a collaborative agreement with Elly’s Team,…
Bristol Myers Squibb’s Sotyktu Makes Global Regulatory Progress for Psoriatic Arthritis as FDA Accepts sNDA for Review In a major development for immunology-focused therapeutics, Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has…
